Ceftriaxone-Induced Immune Hemolytic Anemia

Ceftriaxone is a commonly used antibiotic in hospitals for the treatment of pneumonia, urinary tract infection, bacteremia, meningitis, skin, and soft tissue infection. It can be associated with common allergic reactions like skin rash, itching, and, rarely, angioedema. Ceftriaxone-induced immune he...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Anil, Singhania, Namrata, Sharma, Amit, Sharma, Namita, Samal, Subhankar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2020
Materias:
Infectious Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7370697/
https://www.ncbi.nlm.nih.gov/pubmed/32699660
http://dx.doi.org/10.7759/cureus.8660
_version_ 1783561021500162048
author Singh, Anil
Singhania, Namrata
Sharma, Amit
Sharma, Namita
Samal, Subhankar
author_facet Singh, Anil
Singhania, Namrata
Sharma, Amit
Sharma, Namita
Samal, Subhankar
author_sort Singh, Anil
collection PubMed
description Ceftriaxone is a commonly used antibiotic in hospitals for the treatment of pneumonia, urinary tract infection, bacteremia, meningitis, skin, and soft tissue infection. It can be associated with common allergic reactions like skin rash, itching, and, rarely, angioedema. Ceftriaxone-induced immune hemolytic anemia (IHA) is a rare and potentially fatal complication if not identified and managed in time. We report a case of ceftriaxone-induced IHA in a young woman.
format Online
Article
Text
id pubmed-7370697
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-73706972020-07-21 Ceftriaxone-Induced Immune Hemolytic Anemia Singh, Anil Singhania, Namrata Sharma, Amit Sharma, Namita Samal, Subhankar Cureus Infectious Disease Ceftriaxone is a commonly used antibiotic in hospitals for the treatment of pneumonia, urinary tract infection, bacteremia, meningitis, skin, and soft tissue infection. It can be associated with common allergic reactions like skin rash, itching, and, rarely, angioedema. Ceftriaxone-induced immune hemolytic anemia (IHA) is a rare and potentially fatal complication if not identified and managed in time. We report a case of ceftriaxone-induced IHA in a young woman. Cureus 2020-06-17 /pmc/articles/PMC7370697/ /pubmed/32699660 http://dx.doi.org/10.7759/cureus.8660 Text en Copyright © 2020, Singh et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Infectious Disease
Singh, Anil
Singhania, Namrata
Sharma, Amit
Sharma, Namita
Samal, Subhankar
Ceftriaxone-Induced Immune Hemolytic Anemia
title Ceftriaxone-Induced Immune Hemolytic Anemia
title_full Ceftriaxone-Induced Immune Hemolytic Anemia
title_fullStr Ceftriaxone-Induced Immune Hemolytic Anemia
title_full_unstemmed Ceftriaxone-Induced Immune Hemolytic Anemia
title_short Ceftriaxone-Induced Immune Hemolytic Anemia
title_sort ceftriaxone-induced immune hemolytic anemia
topic Infectious Disease
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7370697/
https://www.ncbi.nlm.nih.gov/pubmed/32699660
http://dx.doi.org/10.7759/cureus.8660
work_keys_str_mv AT singhanil ceftriaxoneinducedimmunehemolyticanemia
AT singhanianamrata ceftriaxoneinducedimmunehemolyticanemia
AT sharmaamit ceftriaxoneinducedimmunehemolyticanemia
AT sharmanamita ceftriaxoneinducedimmunehemolyticanemia
AT samalsubhankar ceftriaxoneinducedimmunehemolyticanemia

Ejemplares similares